• Exchange: NASDAQ CM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Skystar Bio-Pharmaceutical Co

+ Add to Watchlist

SKBI:US

5.7200 USD 0.2099 3.81%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Skystar Bio-Pharmaceutical Co (SKBI)

Open: 5.5300 Day's Range: 5.4500 - 5.7690 Volume: 17,138
Previous Close: 5.5101 52wk Range: 1.0000 - 7.4300 1-Yr Rtn: +281.33%

Stock Chart for SKBI

No chart data available.
  • SKBI:US 5.7200
  • 1D
  • 1M
  • 1Y
5.5101
Interactive SKBI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SKBI

Current P/E Ratio (ttm) 5.2963
Estimated P/E(-) -
Relative P/E vs. SPX 0.3080
Earnings Per Share (ttm) 1.0800
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 43.50
Shares Outstanding (M) 7.60
30 Day Average Volume 77,678
Price/Book (mrq) 0.4066
Price/Sale (ttm) 1.0698
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SKBI

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SKBI

Skystar Bio-Pharmaceutical Company Ltd., on behalf of its parent, manages a biopharmaceutical research, development, and production business. The Company produces veterinary drugs, fodder additive, and microorganism preparation products.

Weibing LuChairman/CEOBing MeiChief Financial Officer
Wei WenSecretary
More Company Profile & Key Executives for SKBI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil